<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>81-OTHER-CORTICOIDES,-ESPECIALLY-INHALED-ONES.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="OTHER CORTICOIDES, ESPECIALLY INHALED ONES" code="D07AC-001" /></DRUG1>
<DRUG2>
<CLASS name="RITONAVIR BOOSTED PROTEASE INHIBITORS" code="J05AE-002" /></DRUG2>
<DESCRIPTION>In case of prolonged use by oral or inhaled route: increase of the plasma concentrations of the corticoid due to decrease of its hepatic metabolism by the protease inhibitor, with risk of appearance of Cushing&#39;s syndrome, even of adrenal insufficiency</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>81-OTHER-CORTICOIDES,-ESPECIALLY-INHALED-ONES.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="OTHER CORTICOIDES, ESPECIALLY INHALED ONES" code="D07AC-001" /></DRUG1>
<DRUG2>
<DRUG name="ITRACONAZOLE" rxcui="28031">
<ATC code="J02AC02" />
</DRUG>
</DRUG2>
<DESCRIPTION>In case of prolonged use by oral or inhaled route: increase of the plasma concentrations of the corticoid due to decrease of its hepatic metabolism by the itraconazole, with risk of appearance of Cushing&#39;s syndrome, even of adrenal insufficiency</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>81-OTHER-CORTICOIDES,-ESPECIALLY-INHALED-ONES.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="OTHER CORTICOIDES, ESPECIALLY INHALED ONES" code="D07AC-001" /></DRUG1>
<DRUG2>
<DRUG name="KETOCONAZOLE" rxcui="6135">
<ATC code="D01AC08" />
<ATC code="G01AF11" />
<ATC code="J02AB02" />
</DRUG>
</DRUG2>
<DESCRIPTION>In case of prolonged use by oral or inhaled route: increase of the plasma concentrations of the corticoid due to decrease of its hepatic metabolism by the ketoconazole, with risk of appearance of Cushing&#39;s syndrome, even of adrenal insufficiency</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>81-OTHER-CORTICOIDES,-ESPECIALLY-INHALED-ONES.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="OTHER CORTICOIDES, ESPECIALLY INHALED ONES" code="D07AC-001" /></DRUG1>
<DRUG2>
<DRUG name="VORICONAZOLE" rxcui="121243">
<ATC code="J02AC03" />
</DRUG>
</DRUG2>
<DESCRIPTION>In case of prolonged use by oral or inhaled route: increase of the plasma concentrations of the corticoid due to decrease of its hepatic metabolism by the voriconazole, with risk of appearance of Cushing&#39;s syndrome, even of adrenal insufficiency</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
</INTERACTIONS>
